Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
11/06/1991 | EP0455396A1 Aqueous gel compositions and their use |
11/06/1991 | EP0454736A1 Fibrinolysis by il-4 |
11/06/1991 | EP0454726A1 Hindered linking agents and methods |
11/05/1991 | US5063210 Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption |
11/05/1991 | US5063064 Lithium fluoride |
11/05/1991 | CA1291748C .beta.-LACTAM ANTIBIOTICS |
10/31/1991 | WO1991016045A2 Use of 5-ht4 receptor antagonists in the treatment of arrythmias and stroke |
10/31/1991 | WO1991016042A1 Controlled release drug formulation |
10/30/1991 | EP0454449A1 Carboxylic acid derivatives |
10/30/1991 | EP0454044A2 Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance |
10/30/1991 | EP0453515A1 Composition for treatment of senile dementia |
10/30/1991 | EP0453497A1 Treatment methods and vaccines |
10/30/1991 | CN1055665A Use of anti-progestomimetic compounds in breeding animals |
10/29/1991 | US5061710 Mercapto-acylamino acid antihypertensives |
10/29/1991 | US5061694 Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor |
10/23/1991 | EP0453097A2 Zusammensetzung enthaltend zumindest zwei verschiedene Antikörper oder deren Fragmente |
10/23/1991 | EP0453001A1 Pharmaceutical composition for the targeted controlled release of an active principle within the intestine, and particularly within the colon |
10/23/1991 | EP0452315A1 Method of treating myeloid leukemias |
10/22/1991 | US5059593 Pour-on formulations which are active against ticks |
10/22/1991 | CA1291036C Nasal administration of drugs |
10/18/1991 | CA2040471A1 Controlled release drug formulation |
10/18/1991 | CA2035155A1 Pharmaceutical composition for the targeted controlled release of an active principle within the intestine, and particularly within the colon |
10/17/1991 | WO1991015241A1 Percutaneously absorbable composition of narcotic and nonnarcotic analgesics |
10/17/1991 | WO1991015233A1 Use of protease nexin-i to mediate wound healing |
10/17/1991 | CA2079783A1 Use of protease nexin-i to mediate wound healing |
10/16/1991 | EP0451880A2 An ex vivo tissue perfusion composition and the use thereof |
10/13/1991 | WO1991016103A1 Improved iontophoretic administration of drugs |
10/13/1991 | CA2080012A1 Iontophoretic administration of drugs |
10/09/1991 | EP0451082A1 Ophthalmic product |
10/09/1991 | EP0450757A2 Use of 5-hydroxytryptamine-antagonists in the treatment of mental disorders originating in childhood |
10/09/1991 | EP0450095A1 Method of assaying d-vanillylmandelic acid, and reagent and kit therefor |
10/09/1991 | EP0449968A1 PROCESS FOR THE PREPARATION OF HUMAN DNase |
10/08/1991 | US5055447 Administering transforming growth factor beta |
10/08/1991 | US5055228 Mixing with dispersion of spheres of lipid laminae |
10/08/1991 | CA1290249C COMBINATION THERAPY USING INTERLEUKIN-2 AND/OR INTERFERON-.beta. AND TUMOR NECROSIS FACTOR |
10/03/1991 | WO1991014455A1 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief |
10/02/1991 | EP0449764A2 A method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor and/or thromboxane receptor antagonist |
10/02/1991 | EP0449463A2 Method and composition for iontophoresis |
10/02/1991 | EP0448895A1 Use of a non-alcoholic delivery system for active ingredients which are ingested orally |
10/01/1991 | US5053419 Administering calcium channel antagonists |
10/01/1991 | US5053388 Coating corneal incision with protein crosslinking compound, applying extra cellular matrix material, both with carriers |
09/27/1991 | WO1991014459A1 A bifunctional dtpa-type ligand |
09/25/1991 | EP0448300A2 Method and composition for coiontophoresis |
09/25/1991 | EP0448299A2 Composition for increased skin concentration of active agents by iontophoresis |
09/25/1991 | EP0448274A2 Use of a thromboxane A2 receptor antagonist for the manufacture of a medicament for the treatment of ulcerative gastrointestinal conditions |
09/25/1991 | EP0311616B1 Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents for treating diseases |
09/24/1991 | US5051443 Wound healing agents for eyes a nonsteroid antiinflammatory agent |
09/24/1991 | US5051435 Pharmaceutical preparations |
09/24/1991 | US5051425 Therapeutic composition for combatting AIDS |
09/24/1991 | US5051257 Antineoplastic solution and method for treating neoplasms |
09/20/1991 | CA2037561A1 Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromboxane a2 receptor antagonist and combination useful in preventing and/or treatingulcers and/or inflammation |
09/19/1991 | WO1991004058A3 Treatment of conditions and disease |
09/18/1991 | EP0447298A1 Method for coating active agents with PH-sensitive polymers |
09/18/1991 | EP0447297A1 Method for coating active agents with zein |
09/18/1991 | EP0446753A1 Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films and their preparation process |
09/18/1991 | EP0446298A1 Fast buccal tablet |
09/17/1991 | WO1991013550A1 Synergistic compositions |
09/17/1991 | US5049589 Antiviral aerosol compositions and pressurized containers containing same |
09/17/1991 | US5049588 Novel treatment for ischemia using an aminotetralin |
09/17/1991 | CA2076530A1 Synergistic compositions |
09/14/1991 | WO1991013898A1 O6-benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing o6-alkylguanine-dna alkyltransferase depleting activity |
09/11/1991 | EP0446124A2 Use of antiprogestomimetics to synchronise parturition in livestock |
09/11/1991 | EP0445239A1 Anti-malarial composition and method of use |
09/11/1991 | EP0445229A1 Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide |
09/11/1991 | EP0445228A1 Immunotherapy involving cd28 stimulation |
09/10/1991 | WO1991013870A1 Mercaptoacyl aminolactam endopeptidase inhibitors |
09/10/1991 | WO1991013618A1 Phenyl butyl nitrone compositions for prevention of gastric ulceration |
09/10/1991 | US5047435 Antiviral compositions containing aromatic polycyclic diones and method for treating retrovirus infections |
09/10/1991 | US5047229 Treatment of cardiovascular and cerebral toxicity using calcium modulators |
09/10/1991 | CA2077746A1 Mercaptoacyl aminolactam endopeptidase inhibitors |
09/10/1991 | CA1288694C Process for treatment of diseases |
09/10/1991 | CA1288688C Method for the diagnosis and treatment of inflammation |
09/09/1991 | CA2037782A1 Process for zein coating of active ingredients |
09/09/1991 | CA2037738A1 Active ingredient coating process using a ph-sensitive polymer |
09/07/1991 | CA2037549A1 Anti-progestomimetic composition used in breeding animals |
09/07/1991 | CA2036750A1 Method and composition for enhancing performance |
09/05/1991 | WO1991012821A1 Oil-in-water emulsion composition containing nonsteroidal antiphlogistic analgesic |
09/05/1991 | WO1991012813A1 Method for treating cancer using combination chemotherapy and brm |
09/05/1991 | WO1991012806A1 Compositions and methods of treatment of sympathetically maintained pain |
09/05/1991 | WO1991011201A3 Compounds |
09/05/1991 | CA2408856A1 Pharmaceutical composition and use for limiting acute or chronic closure of a vascular lumen |
09/04/1991 | EP0444181A1 C-erbb-2 external domain: gp75 |
09/04/1991 | EP0444157A1 Collagen-polymer conjugates |
09/04/1991 | EP0444156A1 Method for treating vascular diseases |
09/04/1991 | EP0293406B1 Solvent system for an ionizable pharmaceutical agent |
09/03/1991 | WO1991013085A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
09/03/1991 | WO1991012792A1 Method and product for promoting hair growth and treating skin conditions |
09/03/1991 | US5045530 Conprising a micelle or a vesicle of a cationic teniside based on a hydrophobic alkyl-substituted pyridinium compound and a hydrophobic drug; drug delivery; skin disorders |
09/03/1991 | US5045320 Large multivalent immunogen |
09/03/1991 | US5044091 Frozen first and second liquid freeze dried together |
09/03/1991 | CA2077345A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
08/23/1991 | CA2036774A1 Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor and/or thromboxane receptorantagonist or a |
08/21/1991 | EP0442141A1 Pharmaceutical preparation |
08/20/1991 | US5041441 Method of chemotherapy using 1-phenyl-2-decanoylamino-3-morpholino-1-propanol |
08/20/1991 | US5041430 Oral anticoagulant/platelet inhibitor low dose formulation |
08/14/1991 | CA2036091A1 Pharmaceutical composition |
08/13/1991 | US5039680 Administering methyl-imidazole substituted carbazolone |
08/13/1991 | CA1287577C Growth promoting compositions |
08/10/1991 | WO1991012003A1 Use of insulin sensitizing agents to treat hypertension |
08/08/1991 | WO1991011201A2 Compounds |